NAYA Biosciences Investor Relations Material
Latest events
Status Update
NAYA Biosciences
Q2 2025
14 Aug, 2025
Q1 2025
21 May, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from NAYA Biosciences Inc
Access all reports
INVO Bioscience Inc develops and markets medical technologies for the treatment of infertility. The company offers devices and solutions designed to enable in vivo fertilization as an alternative to traditional in vitro fertilization procedures. INVO Bioscience operates within the healthcare and medical technology sectors. The company is headquartered in Sarasota, Florida, and its shares are listed on the NASDAQ.
Key slides for NAYA Biosciences Inc
Investor Presentation
NAYA Biosciences Inc
Investor Presentation
NAYA Biosciences Inc
Latest articles
)
Verisure: Security Leader Ready for a Comeback IPO
Verisure, Europe's leading monitored alarm provider, is preparing a comeback IPO in 2025 that could be one of the year's most significant listings.
16 Sep 2025
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
Ticker symbol
NAYA
Country
🇺🇸 United States